| Financial Year |
March 31 2023 |
| Monetary Funds |
303,915,531.99 |
| Held-for-trading Financial Assets |
1,369,869,687.01 |
| Notes Receivable |
-- |
| Accounts Receivable |
259,930,361.06 |
| Advances to Suppliers |
1,524,954.15 |
| Other Receivables |
12,358,565.69 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
690,851.19 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
223,826,017.34 |
| Other Current Assets |
5,780,234.68 |
| Total Current Assets |
2,178,347,091.46 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
45,292,442.19 |
| Investment Properties |
-- |
| Fixed Assetes |
2,365,133,894.66 |
| Under-construction Projects |
7,401,079.19 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
112,762,543.07 |
| R&D expenses |
-- |
| Goodwill |
-- |
| Long-Term Deferred and Prepaid Expenses |
114,269,517.70 |
| Deferred Income Tax Assets |
45,976,783.01 |
| Other Non-Current Assets |
4,742,654.61 |
| Sub-Total of Non-Current Assets |
2,825,223,245.29 |
| Total Assets |
5,003,570,336.75 |
| Short-Term Loans |
-- |
| Trading Financial liabilities |
-- |
| Notes Payable |
68,155,808.72 |
| Accounts Payable |
242,842,371.01 |
| Accounts Received In Advance |
37,271,305.14 |
| Employee Compensation Payable |
130,445,995.98 |
| Taxes Payable |
39,838,587.90 |
| Interest Payable |
-- |
| Dividend Payable |
33,794,742.75 |
| Other payables |
166,437,796.75 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
47,812,110.35 |
| Other Current Liabilities |
606,612.12 |
| Sub-Total of Current Liabilities |
743,520,790.12 |
| Long-term Loans |
-- |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
912,848.34 |
| Deferred Income Tax Liabilities |
25,127,867.09 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
126,303,159.68 |
| Total Liabilities |
869,823,949.80 |
| Paid-In Capital(Or Share Stock) |
297,810,000.00 |
| Capital Surplus |
180,987,949.91 |
| Surplus Reserve |
489,996,140.68 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
2,925,844,894.63 |
| Minority Stockholder's Interest |
239,107,401.73 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
3,894,638,985.22 |
| Owner's Equity（Stockholder's Equity） |
4,133,746,386.95 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
5,003,570,336.75 |
